Ten stocks stood firmer on Tuesday, mimicking a rally in the broader market, as investors took path from a flurry of positive developments, including upbeat company outlooks and analyst upgrades, among others.

On Wall Street, the Nasdaq led the charge, up 0.47 percent. The S&P 500 increased by 0.25 percent, while the Dow Jones grew by 0.10 percent.

In this article, we spotlight 10 of the top-performing companies on Tuesday and detail the reasons behind their gains.

To come up with the list, we only considered the stocks with a $2 billion market capitalization.

10. Elanco Animal Health Inc. (NYSE:ELAN)

Elanco Animal Health rallied for a third consecutive day on Tuesday, jumping 7.61 percent to finish at $25.18 apiece, as investors took heart from its upbeat outlook for the year, to be supported by plans to leverage AI.

At the 2026 KeyBanc Capital Markets Healthcare Forum on the same day, Elanco Animal Health Inc. (NYSE:ELAN) Chief Finance Officer Robert VanHimbergen outlined the company’s growth strategy for this year, including plans to grow its organic revenues by 4 to 6 percent and its adjusted EBITDA by 8 percent.

He said that the company is planning to take advantage of the rapidly growing AI across various operations and pursue mergers and acquisitions to enhance research and development.

The outlook came despite Elanco Animal Health Inc.’s (NYSE:ELAN) dismal earnings performance last year, having swung to a net loss of $232 million from a $338 million net income last year. Revenues, on the other hand, increased by 6 percent to $4.7 billion from $4.44 billion year-on-year.

In the fourth quarter alone, net loss widened by 3,350 percent to $276 million from $8 million in the same period a year earlier, while revenues jumped by 12 percent to $1.144 billion from $1.02 billion year-on-year.

9. BrightSpring Health Services Inc. (NASDAQ:BTSG)

BrightSpring rallied for a second day on Tuesday, jumping 7.81 percent to finish at $42.10 apiece, as investors welcomed the company’s reaffirmed growth outlook for this year.

In a shareholders’ meeting on the same day, BrightSpring Health Services Inc. (NASDAQ:BTSG) maintained its total revenues growth guidance of 11.9 percent to 16.2 percent year-on-year, at $14.45 billion to $15 billion, with the pharmacy segment to contribute the largest chunk.

Pharmacy revenues alone are targeted to jump by 10.1 percent to 14.5 percent at $12.6 billion to $13.1 billion, while provider revenues would surge 26.3 percent to 29.7 percent, from $1.85 billion to $1.9 billion.

Total adjusted EBITDA is also pegged at $760 million to $790 million, or an implied growth of 23.1 percent to 27.9 percent year-on-year.

Last year, BrightSpring Health Services Inc. (NASDAQ:BTSG) swung to a net income of $104.8 million from a $68.9 million net loss in 2024. Net revenues were up by 28.2 percent at $12.9 billion, versus $10.07 billion year-on-year.

In the fourth quarter alone, net income was at $49.6 million, skyrocketing by 1,053 percent to $49.6 million from $4.3 million, while revenues surged by 29.3 percent to $3.5 billion from $2.7 billion.

8. Red Cat Holdings Inc. (NASDAQ:RCAT)

Red Cat bounced back by 9.20 percent on Tuesday to finish at $16.97 apiece, as investors loaded portfolios ahead of the results of its earnings performance in the fourth quarter and full-year 2025, with revenues targeted to soar by 1,800 percent.

Red Cat Holdings Inc. (NASDAQ:RCAT) said that it would hold an earnings conference after market close on Wednesday, March 18. A conference call will be held to elaborate on the results.

The company had earlier provided preliminary revenue figures for the said periods, with the fourth quarter expected to soar by 1,842 percent to a range of $24 million to $26.5 million from only $1.3 million in the same period in 2024.

In the full year alone, Red Cat Holdings Inc. (NASDAQ:RCAT) is expecting to report revenues of $38 million to $41 million, or growth of 153 percent from the $15.6 million in 2024.

“This outperformance was driven by robust demand from defense and government customers, expanding program wins, and our ability to rapidly scale production to meet mission-critical requirements,” Red Cat Holdings Inc. (NASDAQ:RCAT) CEO Jeff Thompson said earlier.

“As we look ahead into 2026, we see continued growth, supported by an increased pipeline, improving operating leverage, and our expanding role as a trusted provider of next-generation unmanned systems,” he noted.

7. Western Digital Corp. (NASDAQ:WDC)

Western Digital extended its winning streak to a third consecutive day on Tuesday, to hit a new all-time high, ahead of the payment of its next quarterly dividend.

At intra-day trading, the stock climbed to its highest price of $314.92 before trimming gains to finish the session just up by 9.64 percent at $313.81 apiece.

According to Western Digital Corp. (NASDAQ:WDC), it would pay 12.5 cents worth of dividends tomorrow, March 18, covering all shareholders of record on March 5.

The dividends followed Western Digital Corp.’s (NASDAQ:WDC) earnings performance in the second quarter of fiscal year 2026, with diluted net income attributable to shareholders soaring 296 percent to $1.8 billion from $455 million in the same period a year earlier. Revenues jumped by 25 percent to $3.02 billion from $2.4 billion year-on-year.

Looking into the third quarter ending April 2026, revenues are targeted at $3.2 billion, plus or minus $100 million. Diluted net earnings per share are also expected at $2.30, plus or minus $0.15.

“Our business continues to strengthen. We expect strong revenue growth and improved profitability driven by continued data center demand and by the adoption of our high-capacity drives,” said Western Digital Corp. (NASDAQ:WDC) Chief Finance Officer Kris Sennesael.

6. Planet Labs PBC (NYSE:PL)

Planet Labs saw its share prices jump by 10.08 percent to close at $27.08 apiece, as investors loaded portfolios ahead of the results of its earnings performance this week.

The company is scheduled to release its financial and operating highlights for the fourth quarter of fiscal year 2026 after market close on Thursday, March 19. A conference call will be held to elaborate on the results.

Planet Labs PBC (NYSE:PL) had earlier provided its revenue growth outlook for the said periods, with the full fiscal year expected to be in the range of $297 million to $301 million, or an implied growth of 21.5 percent to 23 percent year-on-year.

The company also expects to record a positive adjusted EBITDA of $6 million to $8 million, reversing a negative adjusted EBITDA of $10.6 million last fiscal year. Gross margin is projected at 57 to 58 percent.

For the fourth quarter alone, Planet Labs PBC (NYSE:PL) targets revenues at $76 million to $80 million, or an implied growth of 23 percent to 30 percent from the same quarter a year earlier.

However, it projects to swing to a negative adjusted EBITDA of $5 million to $7 million, versus an adjusted EBITDA gain of $2.4 million year-on-year.

While we acknowledge the potential of PL to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than PL and that has 100x upside potential, check out our report about the cheapest AI stock.

Click to continue reading and see the other 5 Stocks That Made Millionaires Today.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge fund investor letters by entering your email below.